Professor Kamalinder K Singh is a Professor of Pharmaceutical Technology and Drug Delivery and the Research Lead at the School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, United Kingdom; heads the Nanomedicine and Innovative Technologies research group within the Faculty of Clinical and Biomedical Sciences; and is Healthcare Lead for the UCLan Centre of Smart Materials. With more than 35 years’ experience in academia, Singh has contributed significantly to the fields of pharmaceutical technology, drug delivery. and nanomedicine through the authoring of over 100 research articles, 18 patents, 12 book chapters, and 60 monographs. Her pioneering research has led to the development of many biocompatible nanoparticle-based platform technologies exploited to deliver drugs across various biological barriers with applications to human health and diseases. Singh serves on the International Steering Committee for “Handbook of Pharmaceutical Excipients,” a joint publication by AAPS Pharmaceutical Press and Royal Pharmaceutical Society, Great Britain. She has provided leadership to 35 major funded research projects and is currently managing several research projects funded by the National Institute of Health, the Academy of Medical Sciences, the British Council and the UK Foreign Commonwealth Development Office. She has supervised 30 ECRs and delivered more than 75 keynotes and invited talks at prestigious forums around the globe.